Renovia expands general counsel role

Mar 20, 2019
Jim O’Connor has been chief attorney since February 2018

Boston, Massachusetts-based medical company Renovia has promoted Jim O’Connor to general counsel and senior vice president for strategic development, effective immediately.

O’Connor joined Renovia as general counsel in February 2018 and has been leading the company’s legal, compliance, quality and regulatory functions. The promotion expands his role to also include corporate business development, manufacturing, program management and overseeing Renovia’s finance team. He will further assist in identifying and implementing programs to improve organizational efficiency and execution.

Before joining Renovia, O’Connor worked for 12 years at United Technologies Corp in legal and business roles. He also served as senior counsel at Noble Environmental Power, a renewable energy developer, where his work focused on project finance, regulatory and employment law matters. He began his legal career at Testa Hurwitz & Thibeault, where his practice focused on securities law, M&A and licensing transactions for private and publicly traded technology companies.

Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to aid women with pelvic floor disorders.

‘Jim has shown remarkable judgment and versatility, and has become a key cross-functional leader,’ says company co-founder, chair and CEO Marc Beer in a statement. ‘In his strategic development role, Jim will partner with the entire Renovia team to develop and implement strategies to maximize return on investment across our technology portfolio. As Renovia continues its growth and prepares for the commercial launch of our next-generation digital therapeutics, he will also help drive potential business development and partnership opportunities.’

‘I look forward to working closely with Marc and everyone at Renovia as we leverage our pipeline of digital therapeutic and diagnostic devices to help create a new standard of care in women’s health,’ says O’Connor in a statement.


Sign up to get stories direct to your inbox
Cs logo Cs logo